3 Biotech Stocks That Skyrocketed This Week
If you like excitement, biotech stocks provided plenty of it over the last several days. And most of the buzz stemmed from the $11.9 billion buyout of Kite Pharma (NASDAQ: KITE) announced by Gilead Sciences (NASDAQ: GILD) on Monday.
But while Kite Pharma stock shot up nearly 30% on the acquisition news and Gilead stock jumped more than 10%, neither company ranked among the best-performing biotech stocks this week. Instead, three smaller biotechs made even greater leaps -- Abeona Therapeutics (NASDAQ: ABEO), Sangamo Therapeutics (NASDAQ: SGMO), and Juno Therapeutics (NASDAQ: JUNO). Here's why these biotech stocks skyrocketed.
Image source: Getty Images.
Source: Fool.com
Gilead Sciences Inc Aktie
114,24 €
0,14 %
Die Gilead Sciences Inc Aktie genießt uneingeschränkte Beliebtheit: Nur Buy-Einschätzungen.
Ein positives, wenn auch bescheidenes, Potenzial für Gilead Sciences Inc mit einem Kursziel von 128 € im Vergleich zum aktuellen Kurs von 114.24 €.
